Veracyte Inc
Change company Symbol lookup
Select an option...
VCYT Veracyte Inc
URRNF Twenty Seven Co Ltd
TWLV Twelve Seas Investment Co II
FLO Flowers Foods Inc
CAJ Canon Inc
WPC WP Carey Inc
PPT Putnam Premier Income Trust
GME GameStop Corp
PSEC Prospect Capital Corp
TDY Teledyne Technologies Inc
Go

Health Care : Biotechnology | Small Cap Growth
Company profile

Veracyte, Inc. is a genomic diagnostics company. The Company, through its scientific platform, which utilizes ribonucleic acid (RNA), whole-transcriptome sequencing combined with machine learning, produces genomic tests. It provides various genomic tests, including Afirma Genomic Sequencing Classifier (GSC), Percepta Bronchial Genomic Classifier, Envisia Genomic Classifier and Afirma Xpression Atlas. It provides GSC tests for thyroid cancer. It provides Percepta Bronchial Genomic Classifier tests for lung cancer. It provides Envisia Genomic Classifier tests for idiopathic pulmonary fibrosis (IPF). Its Afirma Xpression Atlas provides information on gene alterations associated with thyroid cancer, enabling physicians to tailor surgical and treatment decisions at time of diagnosis.

Closing Price
$27.08
Day's Change
1.52 (5.95%)
Bid
--
Ask
--
B/A Size
--
Day's High
27.08
Day's Low
23.98
Volume
(Average)
Volume:
1,043,307

10-day average volume:
992,353
1,043,307
  • Prev Close
    25.56
  • Today's Open
    25.60
  • Day's Range
    23.98-27.08
  • Avg Vol (10-day)
    992.4K
  • Last (time)
    4:00p ET 01/28/22
  • Last (size)
    2
  • 52-Wk Range
    23.98 - 86.03
    LowHigh
  • (02/10/21 - 01/28/22)
    12.93%
  • 77.0%
  • Market Cap
    1.9B
  • Shares Outstanding
    71.0M
  • -1.14
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 1.0
  • 103.77
  • (% of float 01/15/22)
    5.42

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.